Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug

NCT00318747 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

140

Enrollment

NIH

Sponsor class

Stopped Poor enrollment

Conditions

Asthma
Allergy
Allergic Rhinitis
Rhinitis, Allergic, Seasonal

Interventions

DRUG: Amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate (AIC)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]